Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
26%
Contralateral
17%
Preventive Mastectomy
15%
Neoplasm
15%
Body Mass Index
11%
Triple Negative Breast Cancer
11%
Cancer Risk
10%
Inflammatory Breast Cancer
9%
Neoadjuvant Chemotherapy
9%
Mammography
8%
Odds Ratio
8%
Recurrent Disease
7%
Hormone Receptor
7%
Physical Activity
7%
Prospective Study
6%
Disease Free Survival
6%
Biological Marker
6%
Gamma Urogastrone
6%
Diseases
6%
Mastectomy
6%
Hazard Ratio
5%
Adjuvant Therapy
5%
Estrogen Receptor
5%
Epidermal Growth Factor Receptor 2
5%
Cultural Factor
5%
Oncology
5%
Cancer Prevention
5%
Metastatic Carcinoma
5%
Ethnic Disparity
5%
Tamoxifen
5%
Aromatase Inhibitor
5%
Keyphrases
Breast Cancer
27%
Confidence Interval
22%
Breast Cancer Risk
20%
Breast Cancer Recurrence
16%
Odds Ratio
14%
Phase II Study
12%
Non-Hispanic White
11%
Inflammatory Breast Cancer
11%
Metastatic Breast Cancer
10%
White Women
10%
Neoadjuvant Chemotherapy
9%
Pathological Complete Response
9%
Body Mass Index
9%
Contralateral Prophylactic Mastectomy
9%
Breast Cancer Family History
8%
Triple-negative Breast Cancer
7%
Genetic Variants
7%
Trastuzumab
6%
Human Epidermal Growth Factor Receptor 2 (HER2)
6%
Breast Cancer Survivors
6%
Obesity
6%
Epidemiological Risk
6%
Overall Survival
6%
Breast Cancer Patients
5%
Single nucleotide Polymorphism
5%
Residual Cancer Burden
5%
Paclitaxel
5%
Breast Cancer Subtypes
5%
Bi-national
5%
Mastectomy
5%
Disease-free Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
41%
Chemotherapy
19%
Metastatic Breast Cancer
13%
Neoplasm
13%
Malignant Neoplasm
12%
Gamma Urogastrone
10%
Hormone Receptor
9%
Docetaxel
9%
Paclitaxel
8%
Epidermal Growth Factor Receptor 2
7%
Recurrent Disease
7%
Trastuzumab
6%
Everolimus
6%
Triple Negative Breast Cancer
6%
Inflammatory Breast Cancer
5%